No Data
ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
Express News | ChromaDex Granted U.S. Patent Number 10,000,520 C1 Covering The Composition Of Matter For The Disodium Salt Of NMNH
Express News | Chromadex - Continuously Evaluates & Investigates Next-Generation Nad+ Precursors at Forefront of Burgeoning Healthy Aging Category
Express News | Chromadex Secures U.S. Patent for the Composition of Matter of Salt Forms of Nmnh (Dihydronicotinamide Mononucleotide), a Precursor to Nad+
HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target
ChromaDex Analyst Ratings